Table 2.
Means and standard deviations for outcome measures by time and group based on an intent-to-treat analyses
| Outcome | Intervention | Control | Analyses | |||||
|---|---|---|---|---|---|---|---|---|
| Baseline | Post-Intervention | Follow-up | Baseline | Post-Intervention | Follow-up | Time x Group (F)a |
Effect sizeb | |
| MVPA (min/day) | 28.1 ± 9.9 | 43.5 ± 10.7 | 41.1 ± 12.5 | 33.3 ± 10.3 | 29.8 ± 13.2 | 23.4 ± 9.7 | 23.25* | 0.249 |
| Waist circumference (cm) | 99.3 ± 11.7 | 97.2 ± 11.4 | 96.8 ± 11.3 | 96.9 ± 11.5 | 97.2 ± 11.4 | 97.3 ± 11.3 | 61.84* | 0.469 |
| Body mass (kg) | 84.5 ± 9.9 | 82.5 ± 9.6 | 81.7 ± 9.4 | 85.3 ± 8.9 | 85.6 ± 8.8 | 85.7 ± 8.7 | 70.04* | 0.500 |
| BMI (kg/m2) | 31.1 ± 4.0 | 30.4 ± 4.0 | 30.1 ± 3.9 | 30.5 ± 4.2 | 30.6 ± 4.1 | 30.7 ± 4.1 | 71.31* | 0.505 |
| PA self-efficacy (Risk score) | 28 ± 8 | 36 ± 7 | 38 ± 7 | 34 ± 11 | 33 ± 10 | 32 ± 6 | 18.72* | 0.211 |
| HrQoL (Scale) | 0.63 ± 0.08 | 0.62 ± 0.08 | 0.67 ± 0.09 | 0.65 ± 0.07 | 0.65 ± 0.08 | 0.62 ± 0.05 | 18.08* | 0.205 |
| Type 2 diabetes risk (Risk score) | 14 ± 5 | 13 ± 4 | 13 ± 4 | 14 ± 5 | 14 ± 5 | 14 ± 5 | 10.91* | 0.135 |
Group data are means ± standard deviations. MVPA moderate-to-vigorous physical activity, BMI Body mass index, HrQoL Health-related quality of life. *p < 0.001. a interaction effect of time by group on dependent variable; b Partial eta-squared